Voice of America - January 16, 2007
Rose Hoban
Click to download/open (MP3)
Click to download/open (Real Audio)
HIV, the virus that causes AIDS, is an extremely active virus. Scientists have learned that it copies itself in the body billions of times a day. And during that replication process, the virus undergoes subtle changes. In some patients, these mutations can cause many of the individual viruses to become resistant to the anti-retroviral medications used to prevent and treat AIDS.
Now researchers from Duke University in Durham, North Carolina, think they have created a very sensitive test for finding drug-resistant HIV. Dr. Charles Hicks is involved in the research. He says it's important for doctors to know when patients have drug-resistant viruses in their bodies.
"What we've learned unfortunately is that even when resistance is present in lower amounts, it can be very important in the drugs' ability to work and not work, and that can change the way in which we choose our treatments for patients."
There are tests to determine if a patient has medication-resistant HIV, but, Hicks notes, they are not very sensitive. "Currently our standard test says if the virus that you're looking for is one out of five in all the viruses in the patient, we can find it reliably. But the new test allows us to go down to a much lower, finer detail perhaps down to one in 1,000, certainly down to one in 100, which obviously is a huge improvement over one in five."
Hicks says it's important to know as soon as possible if a patient develops drug-resistant HIV. Those who do, slowly get sicker, but doctors can change the medications they prescribe to prevent that from happening.
In addition, Hicks says, patients with drug-resistant forms of the virus can pass those stronger viruses on to other people. He says this is a problem primarily in the United States and Europe, where HIV patients have been treated with anti-retrovirals for close to a decade. He sees that clearly in his research. "In North Carolina, where we've been studying the prevalence of resistance in people who are getting infected now, we find that more than ten percent of people who are getting newly infected in 2006 and 2007 are getting infected with viruses that already have some degree of resistance."
Hicks and his fellow researchers hope to refine their test further, and expect it will be available for more widespread clinical use in several years. He says that's important, because as more people around the world start taking anti-retroviral medications, scientists will need tools to detect and delay the spread of drug-resistant forms of the virus.
070116
VA070109
Copyright © 2007 - Voice of America. You are welcome to use any material that is published by voanews.com, or you may link to any of the web pages that Voice of America has published on the internet. There is no need to request further permission. Should you wish to establish a link to any VOA web pages, please send your request to pubaff@ibb.gov. We would appreciate that credit for any use of VOA material be given to voanews.com, Voice of America, or VOA, and we ask that you not abridge or edit any VOA material which you may use.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, John M. Lloyd Foundation, the National Library of Medicine, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 2007. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2007. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .